# Study of RPT193 in Healthy Adult Male Subjects

> **NCT06087978** · PHASE1 · COMPLETED · sponsor: **RAPT Therapeutics, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** 14C RPT193

## Key facts

- **NCT ID:** NCT06087978
- **Lead sponsor:** RAPT Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-05
- **Primary completion:** 2023-10-12
- **Final completion:** 2023-10-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087978, "Study of RPT193 in Healthy Adult Male Subjects". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06087978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*